Seeking Alpha

Amag Pharmaceuticals (AMAG +5.6%) gains again today, setting another year high as the shares...

Amag Pharmaceuticals (AMAG +5.6%) gains again today, setting another year high as the shares continued to benefit from Friday's release of positive preliminary data from a study on an anemia drug. The IDA-303 study focused on the safety and efficacy of repeat dosing with ferumoxytol in patients with persistent or recurring iron deficiency anemia regardless of the underlying cause and a history of unsatisfactory oral iron therapy or in whom oral iron could not be used.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)